Literature DB >> 16041034

Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Quanshun Zhang1, Inderpal Singh, Abhineet Sheoran, Xiaochuan Feng, John Nunnari, Angela Carville, Saul Tzipori.   

Abstract

Enterocytozoon bieneusi spores derived from rhesus macaque feces were purified by serial salt-Percoll-sucrose-iodixanol centrifugation, resulting in two bands with different specific densities of 95.6% and 99.5% purity and with a recovery efficiency of 10.8%. An ultrastructural examination revealed typical E. bieneusi spores. Twenty-six stable hybridomas were derived from BALB/c mice immunized with spores and were cloned twice by limiting dilution or growth on semisolid medium. Four monoclonal antibodies (MAbs), reacting exclusively with spores, were further characterized. These MAbs specifically reacted with spores present in stools of humans and macaques, as visualized by immunofluorescence, and with spore walls, as visualized by immunoelectron microscopy. A blocking enzyme-linked immunosorbent assay and Western blotting revealed that the epitope recognized by 8E2 was different from those recognized by 7G2, 7H2, and 12G8, which identified the same 40-kDa protein. These MAbs will be valuable tools for diagnostics, for epidemiological investigations, for host-pathogen interaction studies, and for comparative genomics and proteomics.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16041034      PMCID: PMC1201209          DOI: 10.1128/IAI.73.8.5166-5172.2005

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  41 in total

1.  A case of Enterocytozoon bieneusi infection in an HIV-negative renal transplant recipient.

Authors:  S Metge; J T Van Nhieu; D Dahmane; P Grimbert; F Foulet; C Sarfati; S Bretagne
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2000-03       Impact factor: 3.267

Review 2.  Molecular diagnosis of an Enterocytozoon bieneusi human genotype C infection in a moderately immunosuppressed human immunodeficiency virus seronegative liver-transplant recipient with severe chronic diarrhea.

Authors:  A Sing; K Tybus; J Heesemann; A Mathis
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  One-step purification of Enterocytozoon bieneusi spores from human stools by immunoaffinity expanded-bed adsorption.

Authors:  I Accoceberry; M Thellier; A Datry; I Desportes-Livage; S Biligui; M Danis; X Santarelli
Journal:  J Clin Microbiol       Date:  2001-05       Impact factor: 5.948

4.  Microsporidiosis in travelers with diarrhea from the tropics.

Authors:  R López-Vélez; M C Turrientes; C Garrón; P Montilla; R Navajas; S Fenoy; C del Aguila
Journal:  J Travel Med       Date:  1999-12       Impact factor: 8.490

5.  Production of monoclonal antibodies directed against the microsporidium Enterocytozoon bieneusi.

Authors:  I Accoceberry; M Thellier; I Desportes-Livage; A Achbarou; S Biligui; M Danis; A Datry
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

6.  Enterocytozoon bieneusi infection in patients without evidence of immunosuppression: two cases from Zimbabwe found to have positive stools by PCR.

Authors:  T Gumbo; I T Gangaidzo; S Sarbah; A Carville; S Tzipori; P M Wiest
Journal:  Ann Trop Med Parasitol       Date:  2000-10

7.  Purification of Enterocytozoon bieneusi from stools and production of specific antibodies.

Authors:  Abhineet S Sheoran; Xiaochuan Feng; Sabrina Kitaka; Linda Green; Christine Pearson; Elizabeth S Didier; Susan Chapman; James K Tumwine; Saul Tzipori
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

8.  Enterocytozoon bieneusi as a cause of proliferative serositis in simian immunodeficiency virus-infected immunodeficient macaques (Macaca mulatta).

Authors:  L V Chalifoux; A Carville; D Pauley; B Thompson; A A Lackner; K G Mansfield
Journal:  Arch Pathol Lab Med       Date:  2000-10       Impact factor: 5.534

9.  Purification of Enterocytozoon bieneusi spores from stool specimens by gradient and cell sorting techniques.

Authors:  Zuzana Kucerova; Hercules Moura; Gordon J Leitch; Rama Sriram; Caryn Bern; Vivian Kawai; Daniel Vargas; Robert H Gilman; Eduardo Ticona; Aldo Vivar; Govinda S Visvesvara
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

10.  OptiPrep density gradient solutions for mammalian organelles.

Authors:  John M Graham
Journal:  ScientificWorldJournal       Date:  2002-05-29
View more
  12 in total

1.  MyD88-dependent pathway is essential for the innate immunity to Enterocytozoon bieneusi.

Authors:  Q Zhang; X Feng; W Nie; D T Golenbock; H Mayanja-Kizza; S Tzipori; H Feng
Journal:  Parasite Immunol       Date:  2011-04       Impact factor: 2.280

2.  Sensitivity and specificity of a monoclonal antibody-based fluorescence assay for detecting Enterocytozoon bieneusi spores in feces of simian immunodeficiency virus-infected macaques.

Authors:  Inderpal Singh; Abhineet S Sheoran; Quanshun Zhang; Angela Carville; Saul Tzipori
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

3.  Analysis of the beta-tubulin genes from Enterocytozoon bieneusi isolates from a human and rhesus macaque.

Authors:  Donna E Akiyoshi; Louis M Weiss; Xiaochuan Feng; Bryony A P Williams; Patrick J Keeling; Quanshun Zhang; Saul Tzipori
Journal:  J Eukaryot Microbiol       Date:  2007 Jan-Feb       Impact factor: 3.346

4.  Serial propagation of the microsporidian Enterocytozoon bieneusi of human origin in immunocompromised rodents.

Authors:  Xiaochuan Feng; Donna E Akiyoshi; Abhineet Sheoran; Inderpal Singh; Joel Hanawalt; Quanshun Zhang; Giovanni Widmer; Saul Tzipori
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

5.  Identification and Characterization of Three Spore Wall Proteins of Enterocytozoon Bieneusi.

Authors:  Xinan Meng; Haojie Ye; Ziyu Shang; Lianjing Sun; Yaqiong Guo; Na Li; Lihua Xiao; Yaoyu Feng
Journal:  Front Cell Infect Microbiol       Date:  2022-06-20       Impact factor: 6.073

6.  Therapeutic evaluation of polyamine analogue drug candidates against Enterocytozoon bieneusi in a SCID mouse model.

Authors:  Xiaochuan Feng; Venudhar K Reddy; Harriet Mayanja-Kizza; Louis M Weiss; Laurence J Marton; Saul Tzipori
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

7.  Microsporidian infection is prevalent in healthy people in Cameroon.

Authors:  Stephenson W Nkinin; Tazoacha Asonganyi; Elizabeth S Didier; Edna S Kaneshiro
Journal:  J Clin Microbiol       Date:  2007-07-03       Impact factor: 5.948

8.  Antibody-enhanced, Fc gamma receptor-mediated endocytosis of Clostridium difficile toxin A.

Authors:  Xiangyun He; Xingmin Sun; Jufang Wang; Xiaoning Wang; Quanshun Zhang; Saul Tzipori; Hanping Feng
Journal:  Infect Immun       Date:  2009-03-23       Impact factor: 3.441

9.  Genomic survey of the non-cultivatable opportunistic human pathogen, Enterocytozoon bieneusi.

Authors:  Donna E Akiyoshi; Hilary G Morrison; Shi Lei; Xiaochuan Feng; Quanshun Zhang; Nicolas Corradi; Harriet Mayanja; James K Tumwine; Patrick J Keeling; Louis M Weiss; Saul Tzipori
Journal:  PLoS Pathog       Date:  2009-01-09       Impact factor: 6.823

10.  Patterns of genome evolution among the microsporidian parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi.

Authors:  Nicolas Corradi; Donna E Akiyoshi; Hilary G Morrison; Xiaochuan Feng; Louis M Weiss; Saul Tzipori; Patrick J Keeling
Journal:  PLoS One       Date:  2007-12-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.